DFS and OS in triple negative (a, b) and triple unfavorable (c, d)
By A Mystery Man Writer
Description
Mariagrazia BRANDI, University of Ferrara, Ferrara, UNIFE, Department of Life Sciences and Biotechnologies
DFS and OS in triple negative (a, b) and triple unfavorable (c, d)
PDF) Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer
PDF) Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer
DFS and OS in triple negative (a, b) and triple unfavorable (c, d)
Laura MEDRI, Azienda Unità Sanitaria Locale Forlì, Forlì, ASL Forli, Anatomia Patologica
Laura MEDRI, Azienda Unità Sanitaria Locale Forlì, Forlì, ASL Forli, Anatomia Patologica
PDF) Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer
Mariagrazia BRANDI, University of Ferrara, Ferrara, UNIFE, Department of Life Sciences and Biotechnologies
Piero SISMONDI, Professor (Emeritus), Emeritus Professor of Gynaecological Oncology, Università degli Studi di Torino, Turin, UNITO, Dipartimento di Scienze Chirurgiche
PDF) Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer
Rosella SILVESTRINI, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Istituto Tumori di Milano
PDF) Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer
Mariagrazia BRANDI, University of Ferrara, Ferrara, UNIFE, Department of Life Sciences and Biotechnologies
from
per adult (price varies by group size)